SEC Form 4 · accession 0001209191-15-046333
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Julian N Stern
Director
Period of report
May 20, 2015
Accepted (ET)
May 22, 2015 · 6:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 20, 2015 | M | 18,000 | $18.00 | A | 161,068 | D | |
| Common StockF1 | holding | — | — | — | 12,176 | I | See footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $18.00 | May 20, 2015 | M | 6,000 | D | — | Nov 13, 2024 | Common Stock | 6,000 | 0 | D |
| Stock Option (Right to Buy)F2 | $18.00 | May 20, 2015 | M | 12,000 | D | — | Nov 13, 2024 | Common Stock | 12,000 | 0 | D |
Explanation of responses
- F1Shares are held by the reporting person's spouse as sole trustee of various trusts.
- F2Fully vested.